Literature DB >> 27651597

Homocysteine as Predictive Marker for Pregnancy-Induced Hypertension-A Comparative Study of Homocysteine Levels in Normal Versus Patients of PIH and Its Complications.

Laxmi Maru1, Monica Verma1, Neha Jinsiwale1.   

Abstract

OBJECTIVE: To find the correlation between serum homocysteine levels, relevant laboratory investigations and complications associated with PIH.
METHODS: This was a prospective study conducted over 2 years. Two hundred and fourteen cases were studied. They were divided into mild preeclampsia (64), severe preeclampsia (50), eclampsia (32) and control groups (68). Parameters evaluated for statistical analysis were blood pressure, platelet counts, SGOT, SGPT and serum homocysteine levels.
RESULTS: A definite statistical correlation was found between the homocysteine levels and severity of hypertension (8 mmol/l, p = .759). A higher level of homocysteine was also associated with many maternal complications like abruption, retinopathy, MODS, maternal mortality and eclampsia. Sixty-nine out of 87 patients with elevated homocysteine levels were complicated with some or the other condition, making a high percentage of 79.31 %. Patients with normal level of homocysteine delivered healthy babies (88.1 %). There were 6 maternal mortalities and 20 stillbirths in the hyperhomocysteinemia group.
CONCLUSION: Homocysteine levels have a direct statistical correlation with the severity of hypertension and complication with preeclampsia and eclampsia. It can be considered as a reliable predictive marker for PIH and its wide syndrome.

Entities:  

Keywords:  Homocysteine; Maternal mortality and morbidity; Predictive marker; Pregnancy induced hypertension

Year:  2016        PMID: 27651597      PMCID: PMC5016440          DOI: 10.1007/s13224-015-0832-4

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  12 in total

1.  Serum soluble Fas levels in preeclampsia.

Authors:  C D Hsu; H Harirah; H Basherra; G Mor
Journal:  Obstet Gynecol       Date:  2001-04       Impact factor: 7.661

2.  Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction.

Authors:  Rosario D'Anna; Giovanni Baviera; Francesco Corrado; Riccardo Ientile; Domenico Granese; Narciso Carlo Stella
Journal:  Acta Obstet Gynecol Scand       Date:  2004-02       Impact factor: 3.636

3.  Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review.

Authors:  J G Ray; C A Laskin
Journal:  Placenta       Date:  1999-09       Impact factor: 3.481

4.  Interleukin-18 concentrations in pregnancies complicated by preeclampsia with and without IUGR: A comparison with normotensive pregnant women with isolated IUGR and healthy pregnant women.

Authors:  Marzena Laskowska; Katarzyna Laskowska; Jan Oleszczuk
Journal:  Pregnancy Hypertens       Date:  2011-07-23       Impact factor: 2.899

5.  Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease.

Authors:  Mohsen Kerkeni; Faouzi Addad; Maryline Chauffert; Anne Myara; Mohamed Ben Farhat; Abdelhedi Miled; Khira Maaroufi; François Trivin
Journal:  Clin Chem       Date:  2005-11-10       Impact factor: 8.327

6.  Elevated homocyst(e)ine levels with preeclampsia.

Authors:  A Rajkovic; P M Catalano; M R Malinow
Journal:  Obstet Gynecol       Date:  1997-08       Impact factor: 7.661

7.  Folate, vitamin B12, and homocysteine levels in South Asian women with growth-retarded fetuses.

Authors:  Bo Lindblad; Shakila Zaman; Aisha Malik; Helena Martin; Anna Mia Ekström; Sylvie Amu; Arne Holmgren; Mikael Norman
Journal:  Acta Obstet Gynecol Scand       Date:  2005-11       Impact factor: 3.636

8.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

9.  Homocysteine plasma concentration levels for the prediction of preeclampsia in women with chronic hypertension.

Authors:  Gerda G Zeeman; James M Alexander; Donald D McIntire; Sridevi Devaraj; Kenneth J Leveno
Journal:  Am J Obstet Gynecol       Date:  2003-08       Impact factor: 8.661

10.  Underlying disorders associated with severe early-onset preeclampsia.

Authors:  G A Dekker; J I de Vries; P M Doelitzsch; P C Huijgens; B M von Blomberg; C Jakobs; H P van Geijn
Journal:  Am J Obstet Gynecol       Date:  1995-10       Impact factor: 8.661

View more
  6 in total

1.  Association between Serum Homocysteine Levels in Preeclampsia and its Severity among Women in Lagos, South-West Nigeria.

Authors:  A A Oluwole; C M Nwogu; A Sekumade; A Ajepe; K S Okunade
Journal:  West Afr J Med       Date:  2020 Jan-Mar

2.  Association of combined second trimester maternal serum Homocysteine and Uterine Artery Doppler to predict adverse pregnancy outcome.

Authors:  Pooja Ramesh; S Sudha; Vivek Krishnan
Journal:  J Obstet Gynaecol India       Date:  2021-07-06

3.  Is the 1298A>C polymorphism in the MTHFR gene a risk factor for arterial ischaemic stroke in children? The results of meta-analysis.

Authors:  Beata Sarecka-Hujar; Ilona Kopyta; Michal Skrzypek
Journal:  Clin Exp Med       Date:  2018-02-02       Impact factor: 3.984

4.  Methylenetetrahydrofolate Reductase Enzyme Level and Antioxidant Activity in Women with Gestational Hypertension and Pre-eclampsia in Lagos, Nigeria.

Authors:  V O Osunkalu; I A Taiwo; C C Makwe; O J Akinsola; R A Quao
Journal:  J Obstet Gynaecol India       Date:  2019-04-16

Review 5.  Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies.

Authors:  Caterina Tinelli; Antonella Di Pino; Elena Ficulle; Serena Marcelli; Marco Feligioni
Journal:  Front Nutr       Date:  2019-04-24

Review 6.  A Novel Review of Homocysteine and Pregnancy Complications.

Authors:  Chuce Dai; Yiming Fei; Jianming Li; Yang Shi; Xiuhua Yang
Journal:  Biomed Res Int       Date:  2021-05-06       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.